About Lavina Pharma
Lavina Pharma is a Healthcare company. Pharmaceutical manufacturing and exporting of preparations in India. Its Indian entity Lavina Pharmaceuticals Private Limited reported revenue of βΉ27.56 Cr. Lavina Pharma offers products and services including Tablets and Injections. Its focus areas include Pharmaceuticals, Drug Manufacturing, Finished Products and Nutraceuticals.
Company details
Lavina Pharma is recognized as an integrated pharmaceutical export house that was established in 2004, focusing on the manufacturing and global distribution of a broad range of pharmaceutical preparations. Products are supplied to diverse markets, covering therapeutic areas such as analgesics and immunology, with an emphasis on quality manufacturing and regulatory compliance. Affordable medicines and formulations are offered, including finished products and raw materials, to support healthcare needs across continents, while partnerships are formed to expand global presence and ensure access to preventive healthcare solutions.
- SectorsHealthcare
- Phoneβ’β’β’β’ β’β’β’β’
- Website lavinapharma.com
- Legal Name Lavina Pharmaceuticals Pvt Ltd
- Date of Incorporation 03 Dec, 2004
- Jurisdiction Thane, Maharashtra, India
- Indian entity revenue₹27.56 Cr
FY 2025 · -12% YoY
- Indian entity net profit₹67.2 Lakh
FY 2025 · 2% margin
- Indian entity EBITDA₹1.79 Cr
FY 2025 · 7% margin
Associated legal entities of Lavina Pharma
Lavina Pharma operates through Lavina Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Lavina Pharmaceuticals Private Limited CIN U24230MH2004PTC149804 | Active | 03 Dec 2004 | Thane, Maharashtra | ₹27.6 Cr | 2 | View details |
Products & Services of Lavina Pharma
Lavina Pharma offers a comprehensive portfolio of products and services, including Tablets and Injections.
Tablets are manufactured for immediate release and sustained formulations to treat various diseases.
Injections are provided in small volume and dry powder forms for medical treatments across therapeutic areas.
Board of directors of Lavina Pharmaceuticals Private Limited (Lavina Pharma)
Lavina Pharmaceuticals Private Limited is the primary company behind Lavina Pharma. The board of Lavina Pharmaceuticals Private Limited currently have 2 directors; the longest-serving is Jagdish Singh Deb Singh Shawant, appointed in 2004.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Jagdish Singh Deb Singh Shawant DIN 00455793 | Director | 03 Dec 2004 | 21 yrs 11 mo | Lavina Pharmaceuticals Private Limited |
| Mala Jagdish Shawant DIN 00455914 | Director | 03 Dec 2004 | 21 yrs 11 mo | Lavina Pharmaceuticals Private Limited |
Financials of Lavina Pharma
Figures of Lavina Pharmaceuticals Private Limited, the primary company behind Lavina Pharma, for FY 2025. Revenue was ₹27.56 Cr (-12% year on year). Net profit was ₹67.2 Lakh (2% margin). EBITDA was ₹1.79 Cr (7% margin). Revenue has grown at a compounded annual rate of -5% over three years and +4% over five years.
- ₹27.56 CrRevenue · FY 2025 · -12% YoY
- ₹67.2 LakhNet profit · 2% margin
- ₹1.79 CrEBITDA · 7% margin
- ₹25 LakhPaid-up capital
- -5%Revenue CAGR, 3 years
- +4%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Lavina Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Lavina Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lavina Pharma
The primary company behind Lavina Pharma, Lavina Pharmaceuticals Private Limited, reported revenue of βΉ27.56 Cr for FY 2025, down 12% year on year.
Lavina Pharma is recognized as an integrated pharmaceutical export house that was established in 2004, focusing on the manufacturing and global distribution of a broad range of pharmaceutical preparations. Products are supplied to diverse markets, covering therapeutic areas such as analgesics and immunology, with an emphasis on quality manufacturing and regulatory compliance. Affordable medicines and formulations are offered, including finished products and raw materials, to support healthcare needs across continents, while partnerships are formed to expand global presence and ensure access to preventive healthcare solutions.
Lavina Pharma offers Tablets and Injections.
Lavina Pharma operates through Lavina Pharmaceuticals Private Limited.
The legal entities of Lavina Pharma currently have 2 directors, including Jagdish Singh Deb Singh Shawant, Mala Jagdish Shawant.
